SCHEMBL1491849

SCHEMBL1491849

COc1cccc(C(=O)N(C)OC)c1N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.42
LPAR5 Q9H1C0 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
ABCG2 Q9UNQ0 2/20 0.40
HTT P42858 1/20 0.39
ALDH1A1 P00352 3/20 0.39
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KCNK3 O14649 1/20 0.39
KCNK9 Q9NPC2 1/20 0.39
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4575934 0.87 KEAP1 (0.45) CTSDCA12CA1CA2CA7
SCHEMBL307126 0.83 CTSD (0.51) CTSDABCG2HTTNPC1RAB9A
SCHEMBL15618987 0.83 L3MBTL1 (0.39) LPAR5ALDH1A1MAOB
SCHEMBL4098911 0.82 TAS1R3 (0.49) LPAR5CA12CA1CA2CA7
SCHEMBL8577211 0.82 RAB9A (0.52) HTTALDH1A1NPC1TP53MAPT
SCHEMBL13265349 0.82 ABCB1 (0.46) LPAR5CA12CA1CA2CA7
SCHEMBL4804041 0.82 KAT6A (0.47) CTSDLPAR5CA12CA1CA2
SCHEMBL5696214 0.82 CYP2D6 (0.39) LPAR5ALDH1A1SMN1; SMN2KMT2AHSD17B10
SCHEMBL2481460 0.81 LPAR5 (0.42) CTSDLPAR5CA12CA1CA2
SCHEMBL14916617 0.81 CES2 (0.42) LPAR5ALDH1A1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011033225-A2 SUBSTITUTED 3-AMINO-CINNOLIN-4(1H)-ONE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-03-24 WO disclosed
EP-1655289-A1 Quinazoline derivatives, process for their preparation, their use as antimitotics and pharmaceutical compositions comprising said derivatives EMBL (DE) 2006-05-10 EP disclosed